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Technical aspects
The genetic material in an organism can be modified using various mutagenesis techniques. Older techniques, such as chemical mutagenesis, produce entirely random mutations, whereas newer techniques, such as those of genetic engineering, can produce site-specific mutations. A GMO is an organism modified using such genetic engineering techniques. The most common type of genetic engineering begins with extracellular DNA manipulation to construct a vector harboring a specific DNA sequence or gene that is intended to transfer. The vector is transduced into cells or directly into an organism using physical, chemical, or biological methods.
The modified cells, such as protoplasts, callus cells, or embryonic stem cells, are used to generate a GMO that harbors the exogenous DNA sequence.
When the sequence is derived from an unrelated organism, the process is referred to transgenesis. When DNA sequences are transferred between closely related organisms, the process is called cisgenesis, particularly in the genetic engineering of plants. Both transgenesis and cisgenesis can be labor intensive and require time-consuming screens to identify GMOs, especially when dealing with higher organisms. Building on the concept of transgenesis and cisgenesis, genome editing is an advanced genetic engineering technology that can directly modify a gene within a genome. This modification is achieved by enzymes that cause double-stranded breaks (DSBs) in a target sequences and induce DNA repair through Non-Homologous End Joining (NHEJ) or Homology-Directed Repair (HDR) (Box1). The repair systems can subsequently facilitate the efficient creation of the desired mutation even in the genomes of higher organisms.
Genome editing efficiently causes genetic modifications in which one or a few bases are removed, an amino acid substitution of a protein occurs, or a mutation is completely repaired in the resultant organism genome without leaving marked genetic vestiges following the modifications.
Despite the advantages of genome editing, there are still some technical issues. Obtaining a GMO that has an intentional mutation from among arising variants, albeit less laborious than conventional transgenesis or cisgenesis, continues to require screening. The technology may also cause off-target mutagenesis after attaining the desired modification in a target sequence [1] .
The nucleases may fail to induce a biallelic modification in diploid organisms, thereby resulting in an organism with a monoallelic modification [2] . Furthermore, the microinjection of the nuclease mRNAs into zygotes may induce not only germline modifications, but also mosaic modifications in which wild type cells, including germline, and genetically modified cells coexist in the resultant organisms [3] .
Therefore, the research processes using genome editing and the resultant organisms require careful screening and characterization.
Responses by regulatory agencies
In the Cartagena Protocol on Biosafety, the technical legal term that is close to the GMO, "living modified organism" is stipulated as "any living organism However, other mutations may lead to a gain of function [15] . If organisms modified with genome editing in which a gain of function unintentionally arises are released without rigorous risk assessments, they may rapidly affect the local ecosystem by seriously threatening native species. Even if they do not pose a serious threat to native species, the released organisms may negatively impact the environment due to crossbreeding. Notably, a plant with a new trait that occurred in the wild due to the crossbreeding of different GM canola with herbicide resistance was recently discovered in the US [16] .
In order to achieve a better relationship between biotechnology and society, researchers must act with caution, and establish a scientifically valid assessment method for evaluating organisms modified with genome editing.
In particular, with regard to the off-target effect, whole genome sequencing is available to ensure that no off-target mutations develop following genome editing. If the sequencing is time-consuming, researchers must develop a novel, efficient method based on genetic or epigenetic vestiges which are associated with genome editing technology. For instance, in a recent report on a primate modified via CRISPR/Cas-mediated gene targeting, the potential off-target sites were defined and comprehensively investigated in the primate genome [17] . Such an approach can be effective if a scientific and regulatory consensus is reached.
Concluding remarks
Although genome editing demonstrates efficient and effective genetic engineering, the new biotechnology is creating indistinct boundaries in the existing GMO regulations. Under the present conditions, researchers should act with more caution in research and development using genome editing technology compared to traditional genetic engineering technology for the accountability of science. Most importantly, an international harmony is required on this issue, as we experienced at the Asilomar Conference in 1975 [18, 19] . In order to harness the potential of genome editing for future science and broad applications, researchers, private enterprises, and regulators should proactively discuss and establish appropriate regulations based on a scientific assessment. 
